Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective
First International Summit on Interventional PharmacoeconomicsAdvertisement
Related Videos
Leonard B. Saltz, MD, on Interventional Pharmacoeconomics: A Pathway to Better Cancer Care
Leonard B. Saltz, MD, of Memorial Sloan Kettering Cancer Center, discusses interventional pharmacoeconomics as an important tool that can offer patients with cancer more efficacious and cost-effective care. Pharmacoeconomics may help reduce the high costs of cancer therapy, with evidence-based reductions in doses that maintain effective treatment.
Advertisement
Advertisement
Oct
Today In Oncology20
Advertisement
© 2025 HSP News Service, L.L.C.
